Table 2.

MVD assessment in the studied group of patients and the healthy individuals

	Ovarian cancer (n = 58) median vessels/mm2 (range, min–max)	Benign ovarian tumors (n = 35) Median vessels/mm2 (range, min–max)	Normal ovaries (n = 21) median vessels/mm2 (range, min–max)	P value
CD105-MVD	25 (0–57)	6 (0–70)	6 (0–26)	0.0003
CD31-MVD	76 (19–241)	70 (6–399)	60 (31–284)	0.817
CD34-MVD	70 (6–190)	70 (6–386)	114 (31–354)	0.077

CD105-MVD, CD31-MVD, and CD34-MVD refer to MVD assessed with antibodies against CD105, CD31, and CD34, respectively

Bold value is statistically significant (P < 0.05)